Brown, MD, and Victoria Francois, MPH, discuss strategies to address the gap in sleep inequalities affecting Black women.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Researchers conducted a cross-sectional study to assess racial/ethnic disparities in the association between sleep apnea symptoms and metabolic syndrome in young adults.

By Dr. Liji Thomas, MD New research in eClinicalMedicine reveals that nearly half of people with obstructive sleep apnea are ...